Brief: Novogen patent covering cantrixil, trilexium accepted in Australia
Nov 12 (Reuters) - Novogen Ltd NRT.AX : * Patent covering cantrixil and trilexium accepted in Australia * Announced that a patent application covering two of its key lead superbenzopyran (sbp) drug candidates has been accepted in Australia * Source text for Eikon ID:nPn114wJ * Further company coverage NRT.AX ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Kazia Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
Kazia drops on $40 mln equity offering to fund breast cancer drug
Kazia slides after breast cancer drug update, equity offering launch
Brief: Kazia Therapeutics Limited Announces Proposed Public Offering